[go: up one dir, main page]

WO2006090268A3 - Processes for the preparation of alfuzosin and salts thereof and novel crystalline forms of alfuzosin - Google Patents

Processes for the preparation of alfuzosin and salts thereof and novel crystalline forms of alfuzosin Download PDF

Info

Publication number
WO2006090268A3
WO2006090268A3 PCT/IB2006/000431 IB2006000431W WO2006090268A3 WO 2006090268 A3 WO2006090268 A3 WO 2006090268A3 IB 2006000431 W IB2006000431 W IB 2006000431W WO 2006090268 A3 WO2006090268 A3 WO 2006090268A3
Authority
WO
WIPO (PCT)
Prior art keywords
alfuzosin
crystalline forms
processes
preparation
salts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IB2006/000431
Other languages
French (fr)
Other versions
WO2006090268A2 (en
Inventor
Narendra Shriram Joshi
Buddhavarapu Pattabhi Ramam
Kodali Eswara Rao
Shekhar Bhaskar Bhirud
Nitin S Pradhan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glenmark Pharmaceuticals Ltd
Original Assignee
Glenmark Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glenmark Pharmaceuticals Ltd filed Critical Glenmark Pharmaceuticals Ltd
Publication of WO2006090268A2 publication Critical patent/WO2006090268A2/en
Publication of WO2006090268A3 publication Critical patent/WO2006090268A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention provides novel crystalline forms of a.lfuzosin and alfuzosin hydrochloride and processes for their preparation. Also provided are pharmaceutical compositions containing the new crystalline forms.
PCT/IB2006/000431 2005-02-28 2006-02-28 Processes for the preparation of alfuzosin and salts thereof and novel crystalline forms of alfuzosin Ceased WO2006090268A2 (en)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
IN215MU2005 2005-02-28
IN215/MUM/2005 2005-02-28
US66250505P 2005-03-16 2005-03-16
US60/662,505 2005-03-16
IN711/MUM/2005 2005-06-17
IN711MU2005 2005-06-17
US69674305P 2005-07-06 2005-07-06
US60/696,743 2005-07-06

Publications (2)

Publication Number Publication Date
WO2006090268A2 WO2006090268A2 (en) 2006-08-31
WO2006090268A3 true WO2006090268A3 (en) 2006-10-26

Family

ID=36568690

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2006/000431 Ceased WO2006090268A2 (en) 2005-02-28 2006-02-28 Processes for the preparation of alfuzosin and salts thereof and novel crystalline forms of alfuzosin

Country Status (1)

Country Link
WO (1) WO2006090268A2 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070105880A1 (en) * 2005-11-08 2007-05-10 Torrent Pharmaceuticals Limited Process for the preparation of alfuzosin
WO2007074364A1 (en) * 2005-12-26 2007-07-05 Aurobindo Pharma Limited Process for the preparation of alfuzosin
WO2007063556A2 (en) * 2006-12-07 2007-06-07 Msn Laboratories Limited An improved and industrial process for the preparation of alfuzosin hydrochloride and its novel polymorphs
WO2008114272A2 (en) * 2007-03-22 2008-09-25 Cadila Healthcare Limited Process for preparing alpuzosin and crystalline alfuzosin hydrochloride
EP2152697A2 (en) 2007-05-04 2010-02-17 Actavis Group PTC EHF Process for the preparation of alfuzosin and salts thereof
WO2009001369A1 (en) * 2007-06-22 2008-12-31 Alembic Limited An improved process for the preparation of alfuzosin hydrochloride
WO2009007987A1 (en) * 2007-07-11 2009-01-15 Alembic Limited An improved process for the preparation of alfuzosin and its novel polymorph
KR20100044239A (en) * 2007-08-02 2010-04-29 시플라 리미티드 Process for the preparation of alfuzosin hydrochloride
CN108069945A (en) * 2017-12-31 2018-05-25 威海贯标信息科技有限公司 A kind of Alfuzosin novel crystal forms
CN113801069B (en) * 2020-06-15 2024-03-15 鲁南制药集团股份有限公司 Alfuzosin hydrochloride intermediate compound
CN114573569B (en) * 2022-03-30 2023-07-04 邦恩泰(山东)生物医药科技集团股份有限公司 Preparation method of isoquinoline compound

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5315007A (en) * 1990-12-20 1994-05-24 North Carolina State University Process for making DE ring intermediates for the synthesis of camptothecin and camptothecin analogs
WO2006030449A1 (en) * 2004-09-16 2006-03-23 Hetero Drugs Limited Crystalline alfuzosin base

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5315007A (en) * 1990-12-20 1994-05-24 North Carolina State University Process for making DE ring intermediates for the synthesis of camptothecin and camptothecin analogs
WO2006030449A1 (en) * 2004-09-16 2006-03-23 Hetero Drugs Limited Crystalline alfuzosin base

Also Published As

Publication number Publication date
WO2006090268A2 (en) 2006-08-31

Similar Documents

Publication Publication Date Title
WO2006023627A8 (en) Rapamycin polymorph ii and uses thereof
WO2006127933A8 (en) Processes for preparing cinacalcet hydrochloride crystal form i
WO2009025876A3 (en) Crystalline forms of erlotinib hcl and formulations thereof
WO2007048064A3 (en) Amino-pyrimidines as casein kinase ii (ck2) modulators
WO2009084024A3 (en) A process for the preparation of r-sit agliptin and its pharmaceutically acceptable salts thereof
IL173959A0 (en) ?? crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it
SG131857A1 (en) δD-CRYSTALLINE FORM OF IV ABRADINE HYDROCHLORIDE, A PROCESS FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT
SI1752443T1 (en) New crystalline form V of agometaline, the process for its preparation and the pharmaceutical compositions containing it
IL181827A0 (en) Donepezil salts suitable for the preparation of pharmaceutical compositions
SI2210872T1 (en) New crystalline form iii of agometalin, the process for its preparation and pharmaceutical compositions containing it
WO2008051564A3 (en) Crystalline forms of palonosetron hydrochloride
WO2007098273A3 (en) Novel crystalline forms of armodafinil and preparation thereof
WO2006108572A3 (en) Novel crystalline pharmaceutical product
WO2006090268A3 (en) Processes for the preparation of alfuzosin and salts thereof and novel crystalline forms of alfuzosin
WO2007010555A3 (en) Novel crystalline forms of moxifloxacin hydrochloride and process for preparation thereof
WO2007056625A3 (en) Thienopyridine b-raf kinase inhibitors
WO2007062370A3 (en) Calcilytic compounds
WO2006081515A3 (en) Duloxetine hydrochloride polymorphs
WO2008081268A3 (en) Pharmaceutical compositions of entacapone
WO2005102999A3 (en) Crystalline forms of fexofenadine hydrochloride and processes for their preparation
WO2009025792A3 (en) Crystalline forms cinacalcet fumarate and cinacalcet succinate and processes for preparation thereof
ZA200602631B (en) Indanyl-piperazine compounds, a process for their preparation and pharmaceutical compositions containing them
WO2009007747A3 (en) Hydantoin derivatives used as mmp12 inhibitors
ZA200603810B (en) Phenylpyridylpiperazine compounds, a process for their preparation and pharmaceutical compositions containing them
WO2007144699A3 (en) Process for the preparation of alfuzosin

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 06710477

Country of ref document: EP

Kind code of ref document: A2

WWW Wipo information: withdrawn in national office

Ref document number: 6710477

Country of ref document: EP